Clinical research organization India
clinical trials india Welcome

Your success. That’s our commitment at Excel Life Sciences. Everything we do is built around leveraging our expertise and passion to ensure that your clinical trials are successful. As the leading Trial Management Organization in India and through our trusted partnerships worldwide, we have the capabilities and bandwidth to take on any project large or small. And with offices and executive leadership based in the United States, you can be sure that we’re available when you are. Excel Life Sciences mixes a customized consultative approach with industry-leading experience and know-how to get results. Specifically our team’s experience includes:

  • 280 years combined experience in Clinical Medicine, Pharmaceutical Medicine and Biometrics
  • 50 years of regulatory experience and top USA and India regulatory executive’s on the ELS advisory board 
  • 350 successfully conducted clinical trials at over 1000 sites 
  • 135 IND approvals & 20+ NDA approvals in US, Europe & Asia
clinical trials india What's New at ELS

Excel Life Sciences Continues Successful Management of Clinical Trials in India as Regulators work to Improve Review Process

Excel Life Sciences President and Chief Medical Officer, Dr. Vijai Kumar, is featured in a just released story on the evolving clinical research landscape in India.  The article which appears in the web-based publication, eCliniqua, discusses some of the ongoing changes underway to create a more robust, efficient and predictable regulatory review process in India for clinical trials. Dr. Kumar shares information on the approach Excel Life Sciences takes to ensure timely regulatory approval for its clients global clinical trials. The company, with a unique operating model involving deployment of its own onsite clinical research coordinators to each site, prides itself on running ethical trials and delivering data quality and data integrity to its clients. Please click here to read the full article


MacroGenics, Inc., Takeda Pharmaceutical Co. Ltd. Draw Up $1.6B DART Pact

Biotech Boom On Third Coast Proves Everything's Bigger In Texas

CDC Confirms First American Ebola Case In Dallas

Allergan Inc. Quietly Leases A 90,000 Square Feet Space In Texas

Boehringer Ingelheim Corporation To Create 100 New Jobs With $125 Million+ Site Expansion

Mystique Of Theranos, Inc. Founder Grows With Richest Ranking

FDA Slaps Valeant With A Warning Letter

Bristol-Myers Squibb Company Sheds $1.4B In Pension Liabilities By Transferring Risk To

New Blood Test Shows Who Has And Who May Get Cancer, Study

How To Predict Who Will Suffer The Most From Stress, Concordia University Study

Human Ear Impacted By Low Frequency Noises, Ludwig-Maximilians-University Study Shows

No Sign Of Health Or Nutrition Problems From GMO Livestock Feed, University of California, Davis (UCD) Study

Novartis AG Ditches Hepatitis C Drug Dreams, Breaks $440 Million Enanta Pharmaceuticals, Inc. Deal

Revealed: The Best And Worst Places In The World To Grow Old

SF Biotech FibroGen, Inc. Plots $125 Million IPO As It Muscles Its Way Into Fibrosis

Novartis AG To Roll Out 15 Abstracts At

New Genetic Indicators Could Help Solve Malaria Puzzle, University of Melbourne Study

Quest For Peanut That Won't Cause Allergic Reaction Continues: University of Florida/Researcher

Endocyte, Inc. Faces Big Decisions On Cancer Drug Vintafolide

Akorn, Inc. Ponies Up $45 Million Cash For Sunovion Pharmaceuticals Inc.'s Xopenex® (levalbuterol HCI) Inhalation Solution

After Snagging 18 Products From AstraZeneca PLC, IGI Laboratories, Inc. Grabs Two More From Valeant

Portola Pharmaceuticals, Inc.'s ANNEXA™ Reverses Effect Of Anti-Clotting Drugs In Phase 3 Study

Abstracts For Merck & Co., Gilead Sciences, Inc. And AbbVie Look Promising, Says ISI

Ardelyx Inc. Looks Good After Tenanpanor Results: Citi Analysts

GE Corporation, University of California, San Francisco (UCSF), Agencies Partner Up To Define, Attack Traumatic Brain Injuries

Oncore Grabs For Undisclosed Amount

Ardelyx Inc. Irritable Bowel Syndrome Drug Succeeds In Phase 2b Trial

Islet Sciences, BHV Pharma, Inc. Merges; Combined Company To Be Named

Alimera Sciences Receives $25 Million Advance From

Novartis AG Must Face U.S. Lawsuit Over Doctor Kickbacks

Celgene And Sanofi (France) CEOs Among Headliners For Exclusive Event

Drugmakers, Medtechs Paid $3.5 Billion To Doctors And Leading Hospitals

New ??26 Million Medical Research Centre Unveiled In Dundee

Lucideon (Formerly Known As CERAM) To Create 100 New Jobs and Bolster U.S. Presence in Innovation Push

Retrophin, Inc. Announces Leadership Reorganization

Gilead Sciences, Inc. Looks To Erase Bristol-Myers Squibb Company's Early Hep C Lead

Gilead Sciences, Inc. Will Employ 500 People At New SoCal Campus

Johnson & Johnson Bags SSF's Alios BioPharma For $1.7 Billion Cash

Design Power: Patients Play Researchers In Drug Trials

Centers for Disease Control and Prevention (CDC) Investigates Limb Paralysis In Kids; Is Enterovirus To Blame?

Baxter International, Inc. Will House 400 Staffers At New R&D Center In Boston

Sanofi (France), Regeneron Pharmaceuticals, Inc.'s Dupilumab Successful In Phase 2 Study

How Your Fingers Can Predict Everything From Penis Size To Sexual Orientation

Pfizer Starts New Viagra Commercials Targeting Women

Bay Area Startup Allakos Locks In Another $10 Million

Strides Arcolab Limited Snags In All Stock Deal Worth Over $221 Million

Top 10 Fastest Growing Employers Outside Of Big Pharma

Pfizer, Abbott Laboratories Snubbed By Indian PM After Generics Scuffle

Pfizer Will Wait Out Midterm Elections For Favorable Inversion Laws: Analyst

If Allergan Inc. Survives Valeant, AbbVie, Shire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/hire or Actavis/Forest May Be Suitors

Genentech's New Breast Cancer Drug Greatly Extends Survival Rates

Pfizer, Kyowa Hakko Kirin Team Up On Immuno-Oncology Combination Study

MannKind Corporation Pockets $150 Million Upfront Payment From Sanofi (France)

Leidos Awarded $25 Million Task Order By Department Of Veterans Affairs

Consort Medical Scoops Up Aesica For $374 Million

Biotech Firm Backed By Mexican Billionaire Files To Go Public

Nimbus Discovery Appoints As Chief Executive Officer

Mapp Biopharmaceutical's Ebola Drug Production Set for Texas, Possibly North Carolina

CEO Leaves Karolinska Development AB And Board Member Is Appointed Acting CEO

Ritter Pharmaceuticals, Inc. Names Chief Executive Officer

Acasti Pharma Announces Positive Top-Line Pharmacokinetic Results

Merck & Co.'s Keytruda Shows Positive Signs In Bladder Cancer Trial

Sleep Twitches Light Up The Brain, University of Iowa Study

Pfizer's Lung Cancer Drug Xalkori Effective In Rare Gene Trial

Antibiotics "Linked To Childhood Obesity," University of Pennsylvania Study

Healthy Fats Help Diseased Heart Muscle Process, Use Fuel, University of Illinois Study

Childhood Asthma Linked To Lack Of Ventilation For Gas Stoves, Oregon State University Study

Perfectionism Linked To Suicide: York University Psychology Expert

Lead In Chinese Cold Remedy Poisons Toddler

Cells From Placentas Safe For Patients With Multiple Sclerosis, Mount Sinai School of Medicine Study

Ideal Age Of Sexual Partners Differ For Men And Women, Study

Stress Might Be Even More Unhealthy For The Obese, Brandeis University Study

Hundreds Of Firms Join Global Hunt For Copycat Biotech Drugs

In 2-Minute Drill For Startups, A Winning Pitch For Clinical Trials

Ex-Elan Corporation PLC Trio Snags Their Former Employer???s Kinase Inhibitor Program

Daiichi Sankyo, Inc. Boosts Cancer Pipeline With $410 Million Ambit Biosciences Buy

Seattle Genetics, Inc., Takeda Pharmaceutical Co. Ltd.'s Cancer Drug Meets Main Goal In Phase 3 Trial

Hikma Pharmaceuticals Eyeing $1 Billion Bid For U.S. Rival CorePharma LLC

Merck & Co.'s Keytruda Extends Immune System Fight To Stomach Cancer

TONIX Pharmaceuticals, Inc.'s Pain Drug Fails Phase 2b Study

German Alzheimer's Drug Developer Probiodrug AG Plans Amsterdam IPO

"Cascade??? Of Biotech M&A Will Transform Specialty Pharma: Cowen

Analysts Say Valeant Pharmaceuticals International/Allergan Inc. Deal Could Lead To Buying Spree

FDA Says Novartis AG, Roche's Asthma Drug Xolair Raises Risk Of Heart, Brain Problems

Boehringer Ingelheim Corporation's Afatinib Meets Primary Endpoint In Phase 3 Study Of Head And Neck Cancer

7 Foods That Fight High Cholesterol

America???s Highest Paid Female CEO Used To Be Male

Helsinn Group Release: Pivotal Phase 3 Trial Data For Anamorelin In ROMANA 1 And 2 Studies In Non-Small Cell Lung Cancer Patients With Anorexia-Cachexia Shows Significant Increase In Lean Body Mass, Body Weight And Improved Symptoms

AMAG Pharmaceuticals, Inc. Shells Out $675 Million For Women's Health Company Lumara Health

Atox Bio Awarded Contract Worth Up To $24 Million For The Development Of AB103 By The Biomedical Advanced Research and Development Authority (BARDA)

Life Sciences M&A Stays White Hot As Buying Spree Continues

Biomedic Acetaminophen With Codeine: Recall Due To Missing Child-Resistant Packaging

Kamada Ltd. Extends Glassia Agreement With Baxter International, Inc.

Novartis AG Drug Afinitor Is First Treatment For Advanced Pancreatic NET To Provide Overall Survival Of More Than 3.5 Years In Phase 3 Trial

Novartis AG's Sandoz, Inc. Will Move Into Former Novo Nordisk A/S Headquarters In New Jersey

LINK Appoints New CEO

Protalix Biotherapeutics, Inc. Appoints As President And CEO

Horizon Pharma plc. Commercial Chief Resigns; Executive Committee Formed

Novartis AG Oversees Distant Regions From Miami Headquarters

Array BioPharma, Inc. Release: Phase 2 Trial Of Binimetinib In NRAS Melanoma Shows Promising Clinical Activity

Hemispherx Biopharma Expands Research On Potential Ebola Treatments To Five Independent Experts/Institutional Collaborators

Bristol-Myers Squibb Company's Immunotherapy Drug Opdivo Gets Six Month FDA Review For Melanoma

Brain Repair "May Be Boosted By Curry Spice," Study

Autistic Kids Are More Sedentary Than Their Peers, Oregon State University Study Shows

Can Diet Affect Multiple Sclerosis? Brigham and Women's Hospital Study

AVEO Oncology Terminates Cambridge Lease Agreement To Save $110 Million

Drugmakers Like GlaxoSmithKline Are Creating A New Breed Of Account Managers

Six Mini Biotech Hubs Around Boston That Aren???t East Cambridge

India's Pharma Sector Mints Billionaires

Bay Area's Pharmacyclics, Inc. Stock Slumps After Ending Servier Collaboration

Exelixis, Inc. Taps As New CFO

Novo Nordisk A/S To Create 60 Jobs At New Seattle Obesity Center

Biotech Layoffs Often Go Hand-In-Hand With CEO Pay Raises

Valueact Places CEO On Valeant Pharmaceuticals International's Board In Effort To Force Allergan Inc. Takeover

Sanofi (France) Will Create 1,400 Jobs At New Shanghai Research Hub

Sumitomo Dainippon Pharma, SanBio, Inc. Strike $199 Million Stroke Deal

Bay Area Biosimilar Firm Coherus Biosciences Eyes $86.25 Million IPO

Analyst: Novartis AG, Celgene Might Go Toe-to-Toe Over Psoriasis Drugs

Gilead Sciences, Inc.'s Harvoni Will Fast Track: Analyst

Pfizer Delays Start Of Phase 3 Rivipansel Trial, GlycoMimetics, Inc. Shares Fall

Actavis Will Keep Selling Alzheimer's Drug In U.S. For 60 Days

Regado Biosciences, Inc. Slashes 60% Of Workforce

This Little Switch Could Make Gilead Sciences, Inc. Stock Billions

Ebola - It's Far, Far Worse Than You Thought

Convicted ImClone Systems Boss Becomes Chief Of Innovation At Kadmon Corporation While Brother Takes CEO Post


    Read more..